Runben Biotechnology Co., Ltd. (SHA:603193)
China flag China · Delayed Price · Currency is CNY
22.25
-0.43 (-1.90%)
May 27, 2026, 3:00 PM CST

Runben Biotechnology Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9,0029,8039,4477,356--
Market Cap Growth
-36.21%3.77%28.44%---
Enterprise Value
7,8618,6749,0546,808--
Last Close Price
22.2524.2323.0517.66--
PE Ratio
27.8331.1731.4732.54--
Forward PE
23.9224.6626.2726.80--
PS Ratio
5.736.357.177.12--
PB Ratio
3.964.414.543.83--
P/TBV Ratio
4.124.604.663.87--
P/FCF Ratio
51.1752.3151.6230.79--
P/OCF Ratio
30.8435.6236.7329.13--
EV/Sales Ratio
5.005.626.876.59--
EV/EBITDA Ratio
21.9924.9028.0425.94--
EV/EBIT Ratio
23.4326.4629.8728.06--
EV/FCF Ratio
44.6946.2849.4728.50--
Debt / Equity Ratio
00.000.000.000.010.02
Debt / EBITDA Ratio
0.000.000.010.020.040.07
Debt / FCF Ratio
0.010.010.020.020.06-
Net Debt / Equity Ratio
-0.50-0.66-0.69-0.83-0.51-0.45
Net Debt / EBITDA Ratio
-3.20-4.21-4.43-6.09-1.89-1.82
Net Debt / FCF Ratio
-6.49-7.83-7.82-6.69-2.9618.84
Asset Turnover
0.660.680.620.731.161.26
Inventory Turnover
3.535.415.234.644.935.40
Quick Ratio
7.5813.2110.5816.933.973.64
Current Ratio
10.9814.5311.6318.045.284.56
Return on Equity (ROE)
14.69%14.62%15.00%17.10%24.93%29.72%
Return on Assets (ROA)
8.86%8.99%8.94%10.66%15.06%17.69%
Return on Invested Capital (ROIC)
31.13%40.57%53.19%60.54%45.44%45.56%
Return on Capital Employed (ROCE)
14.70%14.70%14.60%12.60%24.30%22.90%
Earnings Yield
3.59%3.21%3.18%3.07%--
FCF Yield
1.95%1.91%1.94%3.25%--
Dividend Yield
2.03%1.90%1.78%0.96%--
Payout Ratio
54.56%56.02%45.32%-2.15%25.65%
Buyback Yield / Dilution
0.87%0.60%-14.85%-3.71%-1.61%-9.69%
Total Shareholder Return
2.88%2.49%-13.07%-2.75%-1.61%-9.69%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.